Trial Profile
A Pilot Study of DPV-001 DRibble Vaccine With Imiquimod in Advanced Prostate Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs DPV 001 (Primary) ; Cyclophosphamide; Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune; Imiquimod
- Indications Adenocarcinoma; Prostate cancer
- Focus Adverse reactions
- Sponsors UbiVac
- 09 Oct 2018 Status changed from recruiting to completed.
- 21 Sep 2014 New trial record